31 January, 2025 14:40:48 IST 
Jubilant Ingrevia Ltd has commissioned its new cGMP compliant facility at Bharuch, Gujarat to manufacture nutraceuticals and dietary-active ingredients.
The 5,000-mt facility is an extension of the company’s USFDA approved plant that is already supplying to the US, Europe, Japan and other markets. It will be fully equipped to cater to the needs of the biggest marquee customers in the food, nutrition and cosmetics space.
The niacinamide made at the new plant, in addition to its various applications in skin and hair care, will help the company enter the infant nutrition market globally, with food grade niacin. “The production of these new grades of Vitamin B3 will significantly enhance the company’s presence within value-added products with this high-value and high-margin offering,” the company said in a press note.
Speaking on the development, Mr. Deepak Jain, CEO & Managing Director, Jubilant Ingrevia said, “The commissioning of our new facility for niacinamide aimed at food, nutrition and cosmetic applications is an important milestone in our journey. We are already one of the world’s largest producers of niacinamide and as we ramp up the utilisation of this new plant, we aim to become global leader in Vitamin B3 in the coming years. With this, we are now among a select few capable of producing high-quality Vitamin B3 for these high-value, high margin offerings. It also gives us a strategic moat, protecting us from industry volatility in feed-grade niacinamide”.
“Given that our value-chain in the Nutrition & Health Ingredients business is fully integrated and follows the green route, our international clients specifically seeking high bio-content products, shall benefit,” he added.
Q3 results
Meanwhile, the company has posted a net profit of Rs. 69-crores for the third quarter ended December 31, 2024 (Q3FY25) – an 80 percent increase over the same year-ago period. Total revenues were at Rs. 1,057-crore for the quarter, representing a rise of around 10 percent over Q3FY24.
Commenting on the company’s performance, Mr. Shyam S Bhartia, Chairman and Mr. Hari S Bhartia, Co-Chairman, Jubilant Ingrevia said, “We are pleased to announce significant year-on-year growth for this quarter, attributed to the enhanced performance of our Speciality Chemicals and Nutrition businesses, as well as to the benefits derived from cost saving initiatives implemented in recent quarters”.
